PHENYTOIN SODIUM
- Product NDC
- 53002-1501
- 11-digit product format
- 530021501
- Labeler code
- 53002
- Product ID
- 53002-1501_5c315d08-f19f-406a-a737-c7ae373fab1a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PHENYTOIN SODIUM
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA040621
- Marketing category
- ANDA
- Marketing start
- 2006-12-12
- Marketing end
- 0000-00-00
- Substance
- PHENYTOIN SODIUM
- Active strength
- 100 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C8 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 2D6 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| be8c0c29-be12-4cae-8e3b-1c71ed6b952c | Product name | 2 | 20250626 |
| e3d31abf-5149-4e77-89a8-0dc73ec106f9 | Product name | 1 | 20210525 |
| b251e19b-cfda-4a5c-8c9c-f4dad5d55ecb | Product name | 2 | 20200303 |
| 031bbc61-0564-1f35-2716-aa5c1d139248 | Product name | 2 | 20141218 |
| cc830ceb-037c-a5c3-ee14-3d82c0e89e70 | Product name | 1 | 20140508 |
| eafc3fd3-6834-3129-5bbb-8a9a495691ab | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53002-1501-0 | PHENYTOIN SODIUM | 100 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 100 | 5 | |
| 53002-1501-3 | PHENYTOIN SODIUM | 30 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 30 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 53002-1501 | PHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [RPK PHARMACEUTICALS, INC.] | 5 | Legacy NDC, 2 package rows | 20230609_7f20cf98-1a63-4eaf-a7ac-fa5d79a045e0.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 855671 | phenytoin sodium 100 MG Extended Release Oral Capsule | PSN | 7f20cf98-1a63-4eaf-a7ac-fa5d79a045e0 | 5 |
| 855671 | phenytoin sodium 100 MG Extended Release Oral Capsule | SCD | 7f20cf98-1a63-4eaf-a7ac-fa5d79a045e0 | 5 |
| 855671 | DPH sodium 100 MG Extended Release Oral Capsule | SY | 7f20cf98-1a63-4eaf-a7ac-fa5d79a045e0 | 5 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 53002-1501-0 | 53002150100 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (53002-1501-0) | 2017-09-01 | 0000-00-00 | No | No | Current |
| 53002-1501-3 | 53002150103 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (53002-1501-3) | 2017-09-01 | 0000-00-00 | No | No | Current |